You are here
FDA Approves Generic Brethine Injection
Teva's Terbutaline Sulfate Injection is a generic equivalent of Brethine(R) Injection, which is marketed by AAI Pharmaceuticals. This product is a bronchodilator indicated for bronchial asthma and for reversible bronchospasm, which may occur with bronchitis and emphysema.
The brand product has annual sales of approximately $44 million.
Source: Teva Pharmaceutical Industries Ltd.